HeartSciences signs equity distribution agreement for up to $50 million with Maxim Group
HSCS•HeartSciences entered a $50 million at-the-market equity distribution agreement with Maxim Group on November 18, 2026; the current prospectus supplement covers up to $3.08 million in common stock sales.




